Question 1

What is the catalog number for Indobufen Impurity 91?

Accepted Answer

The catalog number for Indobufen Impurity 91 is RM-I042618.

Question 2

What sizes are available for Indobufen Impurity 91?

Accepted Answer

Indobufen Impurity 91 is available in the following size(s): 10 mg, 100 mg, 25 mg, 50 mg.

Question 3

How many pack sizes does Indobufen Impurity 91 come in?

Accepted Answer

Indobufen Impurity 91 is available in 4 different pack sizes.

Question 4

Is Indobufen Impurity 91 in stock?

Accepted Answer

Indobufen Impurity 91 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Does this cell line or biologic require a Material Transfer Agreement (MTA)?

Accepted Answer

Some products, including certain cell lines, plasmids, and tissue cultures, are subject to intellectual property terms and may require an MTA before we can ship. We’ll inform you in advance if this product requires one, and additional handling fees may apply.

Question 6

What should I do if I need to report a performance issue with a specific lot of this product?

Accepted Answer

Provide the catalogue number, product name, lot number, and your experimental results to our technical support team. They’ll investigate and, if needed, escalate to the manufacturer, provided the product was used before expiry and stored correctly.

Question 7

What is the isotype of this antibody?

Accepted Answer

Isotype information such as IgG1 or IgG2a is listed in the product specifications on the datasheet, relevant for selecting compatible detection reagents.

Indobufen Impurity 91

Product Specifications

Synonyms

Molecular Formula

Molecular Weight

Target Alternative Name

Available Sizes

Frequently Asked Questions

Explore Other Products

AKR1C3 (N-term) Rabbit Polyclonal Antibody

Alpha-Acetoxyacetic Acid

AREB6 (ZEB1) Human Gene Knockout Kit (CRISPR)

Caspase 3 (CASP3) Mouse Monoclonal Antibody [Clone ID: OTI1D2]

Taf4 Mouse Gene Knockout Kit (CRISPR)

Cluap1 Mouse Gene Knockout Kit (CRISPR)